All Access Articles |
- Intra-Cellular Therapies Submits SNDA for Caplyta in MDD | 2024-12-03 | PHARMACEUTICAL
- Shares of Intra-Cellular Therapies Break Trend as Prices Fall to $72.42. | 2024-06-25 | PHARMACEUTICAL
- Why Are Analysts Bullish on Intra-Cellular Therapies (ITCI)? | 2023-07-28 | PHARMACEUTICAL
- How Does the Market View Intra-Cellular Therapies? | 2023-04-16 | PHARMACEUTICAL